Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in High Risk Patients After Cardiac Surgery
NCT00490828Phase 4Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Jun 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Systemic Inflammatory Response Syndrome (SIRS) and post-traumatic stress disorder (PTSD) comparing Placebo with Hydrocortisone (2 arms). Primary endpoints: Humoral and Cellular Immunologic Markers at 1.5 years, Health Care Related Quality of Life at 1.5 years and 1 more. Started Jun 2007; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00490828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490828.